Shanghai Allist Pharmaceuticals Co., Ltd. News

Shanghai Alice Pharmaceutical Technology Co., Ltd.\'s indicative announcement on the results of the company\'s shareholders\' shareholders\' shareholdings reduction and changes in equity of 1%

Oct 30 00:00

Shanghai Alice Pharmaceutical Technology Co., Ltd. Investor Relations Activity Record Form (October 25, 2024)

Oct 29 17:46

Shanghai Alice Pharmaceutical Technology Co., Ltd. Report for the Third Quarter of 2024

Oct 25 00:00

Announcement of Shanghai Alice Pharmaceutical Technology Co., Ltd. on the change of sponsor representative

Oct 10 00:00

Shanghai Alice Pharmaceutical Technology Co., Ltd. voluntarily disclosed the announcement that AST2303 tablets were approved for drug clinical trials

Sep 24 00:00

Announcement of Shanghai Alice Pharmaceutical Technology Co., Ltd. on participating in the 2024 Semi-Annual Science and Technology Innovation Board Special Group Performance Briefing on Pharmaceuticals and Biological Products

Sep 7 00:00

Announcement of Shanghai Alice Pharmaceutical Technology Co., Ltd. on signing a pharmaceutical technology licensing and development agreement with Gacos

Aug 31 00:00

Shanghai Alice Pharmaceutical Technology Co., Ltd. 2024 Semi-Annual Equity Distribution Implementation Notice

Aug 30 00:00

Shanghai Alice Pharmaceutical Technology Co., Ltd. Investor Relations Activity Record Form (August 2024)

Aug 27 08:30

Announcement of Shanghai Allist Pharmaceuticals Co., Ltd.'s profit distribution plan for the first half of 2024.

Aug 21 00:00

Half-year evaluation report on the company's 'Improving Quality and Efficiency, Returning to Growth' action plan for 2024 by Shanghai Allist Pharmaceuticals Co., Ltd.

Aug 21 00:00

Shanghai Allist Pharmaceuticals Co., Ltd. Semi-Annual Report 2024

Aug 21 00:00

Shanghai Allist Pharmaceuticals Co., Ltd. half-year report summary for 2024.

Aug 21 00:00

Shanghai Allist Pharmaceuticals Co., Ltd. Second Supervisory Board, Eighth Meeting Resolution Announcement.

Aug 21 00:00

Shanghai Allist Pharmaceuticals Co., Ltd.'s Special Report on the Deposits and Actual Use of Funds Raised in the First Half of 2024.

Aug 21 00:00

Announcement on Shareholding Reduction Plan of Shareholder of Shanghai Allist Pharmaceuticals Co., Ltd.

Jul 20 00:00

Announcement by Shanghai Allist Pharmaceuticals Co., Ltd. regarding receipt of proposal from actual controller to implement 2024 interim dividend distribution plan and carry out the "improving quality and efficiency, returning profits" action plan.

Jul 18 00:00

Announcement of Shanghai Allist Pharmaceuticals Co., Ltd. regarding receipt of arbitration notice.

Jul 10 00:00

Shanghai Allist Pharmaceuticals Co., Ltd. voluntarily disclosed an announcement regarding the approval of a new clinical trial of the drug registration certificate for Vandetanib's new indication.

Jul 9 00:00

Investor Relations Activity Log of Shanghai Allist Pharmaceuticals Co., Ltd. (July 2-4, 2024)

Jul 4 18:03